New pill could reduce blood transfusions for thalassemia patients
NCT ID NCT06302491
Summary
This study is testing whether an oral medication called AND017 can help people with β-thalassemia. Researchers want to see if it safely reduces the need for blood transfusions in those who require them regularly, and increases hemoglobin levels in those who don't. The trial involves 64 participants and compares the medication against a placebo while all continue their standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Β-THALASSEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guangxi Medical University No.1 Affiliated Hospital
RECRUITINGNanning, Guangxi, 530021, China
Contact
-
Hainan General Hospital
RECRUITINGHaikou, Hainan, 570203, China
Contact
-
Liuzhou People's Hospital
RECRUITINGLiuchow, Guangxi, 545006, China
Contact
-
Maoming People's Hospital
RECRUITINGMaoming, Guangdong, 525000, China
Contact
-
Nanfang Hospital Southern Medical University
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510515, China
Contact
Conditions
Explore the condition pages connected to this study.